Company news
Tetra Bio-Pharma Inc. news in 2022
Tetra Bio-Pharma Inc.'s news releases, calls and decks from 2022, newest first.
REDUVO™ Marketing Approval on the Right Path
December 22, 2022
Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir
December 6, 2022
Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003
November 29, 2022
Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug Submission
November 18, 2022
Tetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue Ocean
October 27, 2022
Tetra and Prepaire Jointly Apply to BARDA for Funding
October 11, 2022
Tetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue Ocean
September 8, 2022
Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 Patients
September 6, 2022
Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue Ocean
August 11, 2022
Tetra Bio-Pharma Announces Positive Preclinical Results of ARDS-003, a Novel Therapeutic for Sepsis and Viral Infections
August 10, 2022
Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug
July 12, 2022
Tetra Bio-Pharma Opens New Subsidiary in Australia and Provides Regulatory Update
June 6, 2022
Tetra Bio-Pharma Announces Voting Results of 2022 Annual General and Special Meeting
May 31, 2022
Tetra Bio-Pharma Appoints Chief Financial Officer
May 30, 2022
Tetra Bio-Pharma Receives EMA Orphan Drug Designation for a Novel Topical Therapeutic Containing CBD
May 18, 2022
Tetra Bio-Pharma Announces Closing of First Tranche with Cannvalate
May 17, 2022
Tetra Bio-Pharma Announces Licensing Agreement with True North for Patented CBD Technology
May 10, 2022
Tetra Bio-Pharma and Cannvalate Enter Into Partnership
May 5, 2022
Tetra Bio-Pharma's QIXLEEF™ on Track After Type C Meeting with U.S. FDA
March 17, 2022
Tetra Bio-Pharma Provides Update on Research Collaboration with the University of Montreal Hospital Research Centre for Inhaled CBD
March 8, 2022
Tetra Bio-Pharma Provides Management Update
February 28, 2022
Tetra Bio-Pharma Signs License Agreement with Thorne for a Prebiotic Dietary Supplement
February 22, 2022
Tetra Bio-Pharma Receives $4.5M from the Ministère de l'Économie et de l'Innovation/Investissement Québec
February 16, 2022
Avicanna Enters into a Strategic Partnership with Tetra Bio-Pharma
February 14, 2022
Tetra Bio-Pharma Enters into a Strategic Partnership with Avicanna
February 14, 2022